Cargando…

Cognitive performance in idiopathic intracranial hypertension and relevance of intracranial pressure

Cognitive impairments have been reported in idiopathic intracranial hypertension; however, evidence supporting these deficits is scarce and contributing factors have not been defined. Using a case-control prospective study, we identified multiple domains of deficiency in a cohort of 66 female adult...

Descripción completa

Detalles Bibliográficos
Autores principales: Grech, Olivia, Clouter, Andrew, Mitchell, James L, Alimajstorovic, Zerin, Ottridge, Ryan S, Yiangou, Andreas, Roque, Marianne, Tahrani, Abd A, Nicholls, Matthew, Taylor, Angela E, Shaheen, Fozia, Arlt, Wiebke, Lavery, Gareth G, Shapiro, Kimron, Mollan, Susan P, Sinclair, Alexandra J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8421706/
https://www.ncbi.nlm.nih.gov/pubmed/34704028
http://dx.doi.org/10.1093/braincomms/fcab202
_version_ 1783749141336162304
author Grech, Olivia
Clouter, Andrew
Mitchell, James L
Alimajstorovic, Zerin
Ottridge, Ryan S
Yiangou, Andreas
Roque, Marianne
Tahrani, Abd A
Nicholls, Matthew
Taylor, Angela E
Shaheen, Fozia
Arlt, Wiebke
Lavery, Gareth G
Shapiro, Kimron
Mollan, Susan P
Sinclair, Alexandra J
author_facet Grech, Olivia
Clouter, Andrew
Mitchell, James L
Alimajstorovic, Zerin
Ottridge, Ryan S
Yiangou, Andreas
Roque, Marianne
Tahrani, Abd A
Nicholls, Matthew
Taylor, Angela E
Shaheen, Fozia
Arlt, Wiebke
Lavery, Gareth G
Shapiro, Kimron
Mollan, Susan P
Sinclair, Alexandra J
author_sort Grech, Olivia
collection PubMed
description Cognitive impairments have been reported in idiopathic intracranial hypertension; however, evidence supporting these deficits is scarce and contributing factors have not been defined. Using a case-control prospective study, we identified multiple domains of deficiency in a cohort of 66 female adult idiopathic intracranial hypertension patients. We identified significantly impaired attention networks (executive function) and sustained attention compared to a body mass index and age matched control group of 25 healthy female participants. We aimed to investigate how cognitive function changed over time and demonstrated that deficits were not permanent. Participants exhibited improvement in several domains including executive function, sustained attention and verbal short-term memory over 12-month follow-up. Improved cognition over time was associated with reduction in intracranial pressure but not body weight. We then evaluated cognition before and after a lumbar puncture with acute reduction in intracranial pressure and noted significant improvement in sustained attention to response task performance. The impact of comorbidities (headache, depression, adiposity and obstructive sleep apnoea) was also explored. We observed that body mass index and the obesity associated cytokine interleukin-6 (serum and cerebrospinal fluid) were not associated with cognitive performance. Headache severity during cognitive testing, co-morbid depression and markers of obstructive sleep apnoea were adversely associated with cognitive performance. Dysregulation of the cortisol generating enzyme 11β hydroxysteroid dehydrogenase type 1 has been observed in idiopathic intracranial hypertension. Elevated cortisol has been associated with impaired cognition. Here, we utilized liquid chromatography-tandem mass spectrometry for multi-steroid profiling in serum and cerebrospinal fluid in idiopathic intracranial hypertension patients. We noted that reduction in the serum cortisol:cortisone ratio in those undergoing bariatric surgery at 12 months was associated with improving verbal working memory. The clinical relevance of cognitive deficits was noted in their significant association with impaired reliability to perform visual field tests, the cornerstone of monitoring vision in idiopathic intracranial hypertension. Our findings propose that cognitive impairment should be accepted as a clinical manifestation of idiopathic intracranial hypertension and impairs the ability to perform visual field testing reliably. Importantly, cognitive deficits can improve over time and with reduction of intracranial pressure. Treating comorbid depression, obstructive sleep apnoea and headache could improve cognitive performance in idiopathic intracranial hypertension.
format Online
Article
Text
id pubmed-8421706
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-84217062021-12-11 Cognitive performance in idiopathic intracranial hypertension and relevance of intracranial pressure Grech, Olivia Clouter, Andrew Mitchell, James L Alimajstorovic, Zerin Ottridge, Ryan S Yiangou, Andreas Roque, Marianne Tahrani, Abd A Nicholls, Matthew Taylor, Angela E Shaheen, Fozia Arlt, Wiebke Lavery, Gareth G Shapiro, Kimron Mollan, Susan P Sinclair, Alexandra J Brain Commun Original Article Cognitive impairments have been reported in idiopathic intracranial hypertension; however, evidence supporting these deficits is scarce and contributing factors have not been defined. Using a case-control prospective study, we identified multiple domains of deficiency in a cohort of 66 female adult idiopathic intracranial hypertension patients. We identified significantly impaired attention networks (executive function) and sustained attention compared to a body mass index and age matched control group of 25 healthy female participants. We aimed to investigate how cognitive function changed over time and demonstrated that deficits were not permanent. Participants exhibited improvement in several domains including executive function, sustained attention and verbal short-term memory over 12-month follow-up. Improved cognition over time was associated with reduction in intracranial pressure but not body weight. We then evaluated cognition before and after a lumbar puncture with acute reduction in intracranial pressure and noted significant improvement in sustained attention to response task performance. The impact of comorbidities (headache, depression, adiposity and obstructive sleep apnoea) was also explored. We observed that body mass index and the obesity associated cytokine interleukin-6 (serum and cerebrospinal fluid) were not associated with cognitive performance. Headache severity during cognitive testing, co-morbid depression and markers of obstructive sleep apnoea were adversely associated with cognitive performance. Dysregulation of the cortisol generating enzyme 11β hydroxysteroid dehydrogenase type 1 has been observed in idiopathic intracranial hypertension. Elevated cortisol has been associated with impaired cognition. Here, we utilized liquid chromatography-tandem mass spectrometry for multi-steroid profiling in serum and cerebrospinal fluid in idiopathic intracranial hypertension patients. We noted that reduction in the serum cortisol:cortisone ratio in those undergoing bariatric surgery at 12 months was associated with improving verbal working memory. The clinical relevance of cognitive deficits was noted in their significant association with impaired reliability to perform visual field tests, the cornerstone of monitoring vision in idiopathic intracranial hypertension. Our findings propose that cognitive impairment should be accepted as a clinical manifestation of idiopathic intracranial hypertension and impairs the ability to perform visual field testing reliably. Importantly, cognitive deficits can improve over time and with reduction of intracranial pressure. Treating comorbid depression, obstructive sleep apnoea and headache could improve cognitive performance in idiopathic intracranial hypertension. Oxford University Press 2021-09-02 /pmc/articles/PMC8421706/ /pubmed/34704028 http://dx.doi.org/10.1093/braincomms/fcab202 Text en © The Author(s) (2021). Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved. For permissions, please email: journals.permissions@oup.com https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by/4.0/), which permits non-commercial reuse, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Original Article
Grech, Olivia
Clouter, Andrew
Mitchell, James L
Alimajstorovic, Zerin
Ottridge, Ryan S
Yiangou, Andreas
Roque, Marianne
Tahrani, Abd A
Nicholls, Matthew
Taylor, Angela E
Shaheen, Fozia
Arlt, Wiebke
Lavery, Gareth G
Shapiro, Kimron
Mollan, Susan P
Sinclair, Alexandra J
Cognitive performance in idiopathic intracranial hypertension and relevance of intracranial pressure
title Cognitive performance in idiopathic intracranial hypertension and relevance of intracranial pressure
title_full Cognitive performance in idiopathic intracranial hypertension and relevance of intracranial pressure
title_fullStr Cognitive performance in idiopathic intracranial hypertension and relevance of intracranial pressure
title_full_unstemmed Cognitive performance in idiopathic intracranial hypertension and relevance of intracranial pressure
title_short Cognitive performance in idiopathic intracranial hypertension and relevance of intracranial pressure
title_sort cognitive performance in idiopathic intracranial hypertension and relevance of intracranial pressure
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8421706/
https://www.ncbi.nlm.nih.gov/pubmed/34704028
http://dx.doi.org/10.1093/braincomms/fcab202
work_keys_str_mv AT grecholivia cognitiveperformanceinidiopathicintracranialhypertensionandrelevanceofintracranialpressure
AT clouterandrew cognitiveperformanceinidiopathicintracranialhypertensionandrelevanceofintracranialpressure
AT mitchelljamesl cognitiveperformanceinidiopathicintracranialhypertensionandrelevanceofintracranialpressure
AT alimajstoroviczerin cognitiveperformanceinidiopathicintracranialhypertensionandrelevanceofintracranialpressure
AT ottridgeryans cognitiveperformanceinidiopathicintracranialhypertensionandrelevanceofintracranialpressure
AT yiangouandreas cognitiveperformanceinidiopathicintracranialhypertensionandrelevanceofintracranialpressure
AT roquemarianne cognitiveperformanceinidiopathicintracranialhypertensionandrelevanceofintracranialpressure
AT tahraniabda cognitiveperformanceinidiopathicintracranialhypertensionandrelevanceofintracranialpressure
AT nichollsmatthew cognitiveperformanceinidiopathicintracranialhypertensionandrelevanceofintracranialpressure
AT taylorangelae cognitiveperformanceinidiopathicintracranialhypertensionandrelevanceofintracranialpressure
AT shaheenfozia cognitiveperformanceinidiopathicintracranialhypertensionandrelevanceofintracranialpressure
AT arltwiebke cognitiveperformanceinidiopathicintracranialhypertensionandrelevanceofintracranialpressure
AT laverygarethg cognitiveperformanceinidiopathicintracranialhypertensionandrelevanceofintracranialpressure
AT shapirokimron cognitiveperformanceinidiopathicintracranialhypertensionandrelevanceofintracranialpressure
AT mollansusanp cognitiveperformanceinidiopathicintracranialhypertensionandrelevanceofintracranialpressure
AT sinclairalexandraj cognitiveperformanceinidiopathicintracranialhypertensionandrelevanceofintracranialpressure